{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:33:13Z","timestamp":1777915993675,"version":"3.51.4"},"reference-count":71,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p>\n                    Routine pelvic examinations are the core of the periodic gynecological examination and widely tolerated as a necessary part of health maintenance. Is this examination beneficial for asymptomatic women? Justifications for the pelvic examination include screening for\n                    <jats:italic toggle=\"yes\">Chlamydia<\/jats:italic>\n                    (or gonorrhea) infection, evaluation before initiation of hormonal contraception, screening for cervical cancer, and early detection of ovarian cancer. Current nucleic acid amplification tests for\n                    <jats:italic toggle=\"yes\">Chlamydia<\/jats:italic>\n                    and gonorrhea permit the use of urine and self-administered vaginal swabs, which most women prefer over a pelvic examination. Pelvic examination findings do not affect the decision to prescribe or withhold systemic hormonal contraception; a pelvic examination is not needed to initiate these contraceptives. Recent American College of Obstetricians and Gynecologists (ACOG) guidelines recommend less frequent cervical screening, thus decreasing the frequency of a speculum examination for cervical screening. Bimanual examinations for palpation of the uterus and ovaries are also routinely performed in the United States. Clinical trial data, however, show these examinations do not lead to earlier detection of ovarian cancer. No evidence identifies benefits of a pelvic examination in the early diagnosis of other conditions in the asymptomatic woman. Speculum and bimanual examinations are uncomfortable, disliked by many women, and use scarce time during a well woman visit. Eliminating the speculum examination from most visits and the bimanual examination from all visits of asymptomatic women will free resources to provide services of proven benefit. Overuse of the pelvic examination contributes to high healthcare costs without any compensatory health benefit.\n                  <\/jats:p>","DOI":"10.1089\/jwh.2010.2349","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T18:47:45Z","timestamp":1293821265000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":43,"title":["Do New Guidelines and Technology Make the Routine Pelvic Examination Obsolete?"],"prefix":"10.1177","volume":"20","author":[{"given":"Carolyn L.","family":"Westhoff","sequence":"first","affiliation":[{"name":"Columbia University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi E.","family":"Jones","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Guiahi","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22487"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646206778113069"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612123352417"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2005.10.008"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.17.2232"},{"key":"e_1_3_2_7_2","first-page":"493","article-title":"Pelvic examination of asymptomatic women\u2014Attitudes and clinical practice","volume":"37","author":"Stewart RA","year":"2008","unstructured":"Stewart RA, , Thistlethwaite J, , Evans R. Pelvic examination of asymptomatic women\u2014Attitudes and clinical practice. Aust Fam Physician, 2008; 37:493\u2013496.","journal-title":"Aust Fam Physician"},{"key":"e_1_3_2_8_2","first-page":"873","article-title":"Routine pelvic examination for asymptomatic women\u2014Exploring the evidence","volume":"35","author":"Stewart RA","year":"2006","unstructured":"Stewart RA, , Thistlethwaite J. Routine pelvic examination for asymptomatic women\u2014Exploring the evidence. Aust Fam Physician, 2006; 35:873\u2013877.","journal-title":"Aust Fam Physician"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-2-200707170-00172"},{"key":"e_1_3_2_10_2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski KA","year":"2006","unstructured":"Workowski KA, , Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep, 2006; 55:1\u201394.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342103"},{"key":"e_1_3_2_12_2","first-page":"362","article-title":">Chlamydia screening among sexually active young female enrollees of health plans\u2014United States, 2000\u20132007","volume":"58","year":"2009","unstructured":">Chlamydia screening among sexually active young female enrollees of health plans\u2014United States, 2000\u20132007. MMWR, 2009; 58:362\u2013365.","journal-title":"MMWR"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000190092.59482.96"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000190057.61633.8d"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31815d968d"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.8.2129-2132.1997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.153.2.119"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31816ddb9a"},{"key":"e_1_3_2_19_2","volume-title":"Expert Consultation Meeting Summary Report","author":"Association of Public Health Laboratories & Centers for Disease Control and Prevention","year":"2009","unstructured":"Association of Public Health Laboratories & Centers for Disease Control and Prevention. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Consultation Meeting Summary Report, 2009."},{"key":"e_1_3_2_20_2","unstructured":"Preventx. Could you have Chlamydia? www.preventx.com\/. 2010 June 14."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000200497.14326.fb"},{"key":"e_1_3_2_22_2","volume-title":"Department of Reproductive Health and Research. Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Department of Reproductive Health and Research. Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use, 2nd. Geneva: WHO, 2000.","edition":"2"},{"key":"e_1_3_2_23_2","unstructured":"U.S. Food and Drug Administration. Labeling guidance text for combination oral contraceptives prescribing information physician labeling 1994(Docket number: 2000D-1350)www.fda.gov\/ohrms\/dockets\/dailys\/04\/may04\/050604\/050604.htm. 2010 January 4."},{"key":"e_1_3_2_24_2","volume-title":"Manual of medical standards and guidelines: Hormonal contraceptive use","author":"Planned Parenthood Federation of America","year":"1999","unstructured":"Planned Parenthood Federation of America. Manual of medical standards and guidelines: Hormonal contraceptive use. New York: PPFA National Medical Commitee, 1999."},{"key":"e_1_3_2_25_2","volume-title":"Educational bulletin: Oral contraceptives for adolescents: Benefits and safety in health care for adolescents","author":"American College of Obstetricians and Gynecologists","year":"2003","unstructured":"American College of Obstetricians and Gynecologists. Educational bulletin: Oral contraceptives for adolescents: Benefits and safety in health care for adolescents. Washington, DC: ACOG, 2003."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c6f8a4"},{"key":"e_1_3_2_27_2","unstructured":"An overview of abortion in the United States. 2005. www.guttmacher.org\/media\/presskits\/2005\/06\/28\/abortionoverview.html. 2010 January 5."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23339"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61450-0"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e3181585870"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071430"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61480-9"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70360-2"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2004.011858"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.01.023"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31804a8285"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X07302128"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.09.015"},{"key":"e_1_3_2_40_2","first-page":"593","article-title":"Accuracy of the pelvic examination in detecting adnexal masses","volume":"96","author":"Padilla LA","year":"2000","unstructured":"Padilla LA, , Radosevich DM, , Milad MP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol, 2000; 96:593\u2013598.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_41_2","first-page":"145","article-title":"Ovarian cancer: Epidemiologic and clinical perspectives and the feasibility of screening","volume":"2","author":"Bass KM","year":"1995","unstructured":"Bass KM, , Westhoff C, , Bush TL. Ovarian cancer: Epidemiologic and clinical perspectives and the feasibility of screening. Menopause, 1995; 2:145\u2013158.","journal-title":"Menopause"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-198406000-00001"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13733.x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb139967.x"},{"key":"e_1_3_2_45_2","first-page":"759","article-title":"Screening for ovarian cancer: Recommendation statement","volume":"71","author":"U.S. Preventive Services Task Force","year":"2005","unstructured":"U.S. Preventive Services Task Force. Screening for ovarian cancer: Recommendation statement. Am Fam Physician, 2005; 71:759\u2013762.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.06.030"},{"key":"e_1_3_2_47_2","first-page":"357","article-title":"The PMPO syndrome (postmenopausal palpable ovary syndrome)","volume":"22","author":"Barber HR","year":"1972","unstructured":"Barber HR, , Graber EA. The PMPO syndrome (postmenopausal palpable ovary syndrome) CA Cancer J Clin, 1972; 22:357\u2013359.","journal-title":"CA Cancer J Clin"},{"key":"e_1_3_2_48_2","first-page":"1413","article-title":"ACOG committee opinion No. 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer","volume":"100","author":"American College of Obstetricians and Gynecologists","year":"2002","unstructured":"American College of Obstetricians and Gynecologists. ACOG committee opinion No. 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Obstet Gynecol, 2002; 100:1413\u20131416.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70026-1"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(18)30139-9"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-2-199407150-00011"},{"key":"e_1_3_2_52_2","first-page":"16","article-title":"Ovarian cancer: Screening, treatment and follow-up","volume":"12","author":"National Institute of Health","year":"1994","unstructured":"National Institute of Health. 1994. Ovarian cancer: Screening, treatment and follow-up. NIH Consensus Statement, 12:16\u201317.","journal-title":"NIH Consensus Statement"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.05.005"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0901926"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318183fbab"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2005.00728.x"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20063"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1343"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000151991.09124.bb"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.02.004"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cej.0000236250.71113.7c"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0070(84)80008-X"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/1054-139X(94)90262-3"},{"key":"e_1_3_2_64_2","first-page":"362","article-title":"Chlamydia screening among sexually active young female enrollees of health plans\u2014United States, 2000\u20132007","volume":"58","author":"United States Centers for Disease Control and Prevention","year":"2009","unstructured":"United States Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans\u2014United States, 2000\u20132007. MMWR, 2009; 58:362\u2013365.","journal-title":"MMWR"},{"key":"e_1_3_2_65_2","volume-title":"Sexually transmitted disease surveillance 2007 supplement: Chlamydia prevalence monitoring project annual report 2007","author":"United States Centers for Disease Control and Prevention","year":"2009","unstructured":"United States Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2007 supplement: Chlamydia prevalence monitoring project annual report 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevntion, 2009."},{"key":"e_1_3_2_66_2","volume-title":"Guidelines for women's health care: A resource manual","author":"American College of Obstetricians and Gynecologists","year":"2007","unstructured":"American College of Obstetricians and Gynecologists. Guidelines for women's health care: A resource manual, 3rd. Washington, DC: ACOG, 2007.","edition":"3"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji115"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1040"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.2307\/2991539"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198211183072104"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.23.2789"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.90"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2010.2349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2010.2349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2010.2349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:35:04Z","timestamp":1777656904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2010.2349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1089\/jwh.2010.2349"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2010.2349","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}